P2/3, N=126, Not yet recruiting, Beijing Suncadia Pharmaceuticals Co., Ltd

Combined proteomics and lipidomics analyses was conducted on plasma from 265 patients with acute MI from the PACMAN-AMI (Effects of the PCSK9 Antibody Alirocumab on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction) randomized, placebo-controlled PCSK9 mAb trial and 34 patients without MI with hyperlipidemia from the Vienna Lipid Clinic registry, also receiving PCSK9 mAbs...Combining PCSK9 mAbs with high-intensity statins mitigates post-MI increases in lipoprotein(a). URL: https://www.clinicaltrials.gov; Unique identifier: NCT03067844.

P=N/A, N=40, Recruiting, General Hospital of Shenyang Military Region

P=N/A, N=1862, Completed, Shanghai Zhongshan Hospital | Active, not recruiting --> Completed | N=912 --> 1862

P=N/A, N=60, Recruiting, The Affiliated Hospital of Xuzhou Medical University; The Affiliated Hospital of Xuzhou Medical University, Xuzhou City, Jiangsu Province

P=N/A, N=500, Not yet recruiting, The First Hospital of Qinhuangdao; The First Hospital of Qinhuangdao

P=N/A, N=132, Recruiting, The Affiliated Hospital of Xuzhou Medical University; The Affiliated Hospital of Xuzhou Medical University, Xuzhou City, Jiangsu Province

P=N/A, N=60, Not yet recruiting, The First Affiliated Hospital of Xi'an Jiaotong University; The First Affiliated Hospital of Xi'an Jiaotong University

P=N/A, N=1770, Not yet recruiting, The Seventh Affiliated Hospital Sun Yat-sen University; The Seventh Affiliated Hospital of Sun Yat-sen University

P=N/A, N=30, Not yet recruiting, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine; Renji Hospital Affiliated to Shanghai Jiao Tong University School of Me

P=N/A, N=268, Not yet recruiting, The Sixth Medical Center of PLA General Hospital; The Sixth Medical Center of PLA General Hospital

P4, N=100, Not yet recruiting, The First Affiliated Hospital of Nanjing Medical University; The First Affiliated Hospital of Nanjing Medical University